Kaman C Kim

Title: Kaman C Kim: Innovator in NKG2D Ligand Research

Introduction

Kaman C Kim is a notable inventor based in San Bruno, California. He has made significant contributions to the field of biotechnology, particularly in the development of modified NKG2D ligands and receptors. With a total of three patents to his name, his work has implications for therapeutic applications in immunology.

Latest Patents

Kaman's latest patents focus on the production of polypeptides comprised of modified α1-α2 domains of NKG2D ligands. These ligands are designed to bind specifically to a non-natural ectodomain of a non-natural NKG2D receptor. His work also includes the engineering of modified forms of the NKG2D receptor to enhance and diminish binding to both natural and non-natural versions of NKG2D ligands. Additionally, he has developed non-natural NKG2D receptors that do not directly signal or activate the cells to which they are attached, providing a novel approach to cell signaling.

Career Highlights

Throughout his career, Kaman has worked with prominent organizations such as Xyphos Biosciences Inc. and the J. David Gladstone Institutes. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Kaman has collaborated with notable colleagues, including Nigel Killeen and Eytan Herzig. These partnerships have further enriched his research and innovation in the biotechnology sector.

Conclusion

Kaman C Kim's innovative work in the field of NKG2D ligands and receptors showcases his dedication to advancing biotechnology. His patents reflect a commitment to developing novel solutions that could have significant therapeutic implications.